Move of the month

Janssen promoted Maria Walsh to Business Unit Director

Janssen has announced the appointment of Maria Walsh as Business Unit Director, Oncology & Haemotology, Cell & Gene Therapy and Pulmonary Hypertension for Janssen UK.
Speaking about her new role, Maria said: “I am thrilled to start my new role as Business Unit Director. Over the last two years, I have proudly witnessed first-hand the hard work and dedication shown by the Janssen team as they successfully collaborate to deliver excellent outcomes. I look forward to leading the Oncology, Haematology, Cell & Gene Therapy and Pulmonary Hypertension franchises for Janssen UK, guided by our Credo to continue our longstanding commitment to the patients we serve, and our employees.”
Gaëtan Leblay, Managing Director, Janssen UK and Ireland, comments, “Maria is not only an experienced leader in Oncology, she is also a strategic thinker with an empathic and thoughtful management style. This is something she has previously drawn upon to navigate her team through complex and uncertain times with outstanding results. On behalf of the Janssen UK leadership team, I would like to extend a warm welcome to Maria Walsh and wish her every success in her new role”.